Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17737.RAb1j8n0TfTvg0zKzJpkj1_xEOk64c1XNfTuoa2iaNRcM130_provenance.
• NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP33573.RAXEYQB0QUK3VqFyXu2dZB9tKcTR4bHPGJCYmlhArQEuQ130_provenance.
• NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_provenance.
• NP378800.RAKuv6iF-BEhYNnZtyyrJiEoYyEKsCXNKDxtRrrEAzFqM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378800.RAKuv6iF-BEhYNnZtyyrJiEoYyEKsCXNKDxtRrrEAzFqM130_provenance.
• assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663314.RAyKryi49tZkro-krwJDGHHmAXqM7hZcku50oNZ4YW1EU130_provenance.
• NP445738.RAXlft2H3dfoJbZqI1LnvkQfVGEJSBjtcx4y28F5mIxtM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445738.RAXlft2H3dfoJbZqI1LnvkQfVGEJSBjtcx4y28F5mIxtM130_provenance.
• NP16832.RA-82kXlm7cSZ-GzI6dYq_sr9K83ELQL-ujyuBYqHaSmg130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16832.RA-82kXlm7cSZ-GzI6dYq_sr9K83ELQL-ujyuBYqHaSmg130_provenance.
• assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP770565.RAipzQmseKyLG4ECI6XxbVlgzwYWVFXFxTEKeugA_aRcM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770565.RAipzQmseKyLG4ECI6XxbVlgzwYWVFXFxTEKeugA_aRcM130_provenance.
• NP890985.RADu7cikkw3MaqGS3djmFuW_u3yXlNWYtvQL0E2PPTyI4130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890985.RADu7cikkw3MaqGS3djmFuW_u3yXlNWYtvQL0E2PPTyI4130_provenance.
• NP34108.RAGuElQIcoB5o4rvXHfN68BNqlxolGv1A0xEiUOW8LtXs130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP34108.RAGuElQIcoB5o4rvXHfN68BNqlxolGv1A0xEiUOW8LtXs130_provenance.
• NP890984.RALdXPuk71Mv7Rh2VJSmgQJy6EBICd-GUaO_ghCiDZwqw130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890984.RALdXPuk71Mv7Rh2VJSmgQJy6EBICd-GUaO_ghCiDZwqw130_provenance.